Osteochondrodystrophic lesions in chelated thalassemic patients: an histological analysis

Some patients affected by thalassemia major and treated with an iron-chelating drug such as deferioxamine can suffer from severe osteochondrodystrophic lesions of the long bones. These lesions were radiologically and clinically evident in 2.8% of the patients we examined over the last 10 years. The...

Ausführliche Beschreibung